NEW_CURA-LEAF_1170x120_OCT

Boiron celebrates grand opening of new headquarters

Boiron celebrates grand opening of new headquarters

NEWTON SQUARE, Pa. — Homeopathic medicine manufacturer Boiron Inc. celebrated the grand opening of its new headquarters here at 4 Campus Boulevard Tuesday, September 17. The new building is adjacent to the company’s old headquarters, but at some 32,000 square feet, is double the size. Boiron, which has 3,700 employees and distribution in 59 countries,

Changing retail landscape focus of Emerson Industry Day

Changing retail landscape focus of Emerson Industry Day

PHILADELPHIA — With digital marketing and e-commerce creating a tsunami of change across the retail industry, accentuated by Amazon’s seemingly unstoppable growth and the emergence of Alibaba, China’s giant e-commerce company, it was fitting that “Adaptability” was the theme of Emerson Group’s annual Industry Day event, held here Wednesday at the Ritz-Carlton. Or, as Ed

Walgreens teams up with The Skin Cancer Foundation

Walgreens teams up with The Skin Cancer Foundation

NEW YORK — Walgreens has joined The Skin Cancer Foundation on the road this year in support of its Destination: Healthy Skin Program — a national effort to educate consumers about the importance of effective sun protection for skin cancer prevention, and the importance of early detection. “As people spend more time outside enjoying their

Generics will be a leading factor in the company’s advance

PRINCETON, N.J. — A biochemist by training, Marc Kikuchi’s experience stretches across the entire landscape of the pharmaceutical industry. He’s run the gamut — from consultant to entrepreneur, from involvement in wholesale to working with generics — and now finds himself at the helm of North America Generics at Dr. Reddy’s Laboratories Ltd. Kikuchi became

Curaleaf to acquire Select, the leading cannabis wholesale brand in the U.S.

WAKEFIELD, Mass. — Curaleaf Holdings, Inc., a leading vertically integrated cannabis operator in the United States, has signed a definitive agreement to acquire the state-regulated cannabis business of Cura Partners, Inc., owners of the Select brand, in an all-stock transaction valued at C$1.27 billion or US$948.8 million. The acquisition includes Select’s manufacturing, processing, distribution, marketing

McKesson highlights power of community pharmacy in Vegas

McKesson highlights power of community pharmacy in Vegas

LAS VEGAS — McKesson ideaShare 2018, McKesson Corporation’s annual interactive forum for community pharmacists, kicked off today in Las Vegas. The annual event offers those in community pharmacy the opportunity to improve their knowledge, performance and profitability while networking with industry experts. Featured at this year’s event is Health Mart Atlas, the nation’s largest PSAO (pharmacy

Walgreens joins pioneering health science project

Walgreens joins pioneering health science project

LA JOLLA, Calif. — A nationwide consortium led by the National Institutes of Health (NIH) will launch the All of Us Research Program on Friday, May 6, which is being hailed as a pioneering research initiative that will use advance technologies and engage participants as citizen-scientists to embark on a new era of health science and precision medicine. Through

NACDS Foundation sponsors March of Dimes Gourmet Gala

NACDS Foundation sponsors March of Dimes Gourmet Gala

ARLINGTON, Va. — During the March of Dimes Gourmet Gala in Washington Tuesday, April 17, the National Association of Chain Drug Stores (NACDS) Foundation returned as a Platinum Sponsor of the event. The Gourmet Gala makes possible research, education, advocacy and programs that “help more moms have full-term pregnancies and healthy babies.” The Gourmet Gala

Novartis appoints John Tsai head of global drug development and chief medical officer

Novartis appoints John Tsai head of global drug development and chief medical officer

BASEL, Switzerland — Novartis has appointed John Tsai as the company’s head of global drug development (GDD) and chief medical officer and will begin his new role on May 1. Tsai will report to Novartis CEO Vas Narasimhan and will become a member of the company’s executive committee. Tsai succeeds Narasimhan who became CEO of

1 2 3 5